Avoid alcohol intake while using glipizide as it can cause some side effects like low blood sugar level, nausea, vomiting, headache, rapid heartbeat, weakness and sudden changes in blood pressure (1 ...

Learn everything you need to know about Glipizide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Moderate-risk patients with diabetes treated with a sulfonylurea appear to be at a higher risk of major adverse cardiovascular events than those who receive a dipeptidyl peptidase-4 (DPP-4) inhibitor, ...

Glipizide/metformin HCl; 2.5mg/250mg, 2.5mg/500mg, 5mg/500mg; tabs. Adjunct to diet and exercise in type 2 diabetes, as initial therapy or as second-line therapy when response to a sulfonylurea or ...

Sitagliptin and glipizide monotherapy is safe and effective in patients with type 2 diabetes and end-stage renal disease (ESRD) requiring dialysis, researchers reported online ahead of print in the ...

Glipizide 2.5mg, 5mg, 10mg; ext-rel tabs. Glipizide primarily lowers blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the ...

Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy. (HealthDay News) — For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk ...

SHANGHAI, China — The use of metformin significantly reduced the risk of cardiovascular events among diabetic patients with coronary artery disease when compared with the sulfonylurea glipizide, ...

We describe a patient with Stevens-Johnson syndrome (erythema multiforme major) associated with an increase in glipizide dosage administration. Glipizide is a second-generation sulfonylurea commonly ...

The authors describe the development of an inclusion complex of GLZ and formulated an extended-release dosage form based on osmotic technology. The earliest studies in the field of modified drug ...